The human and mouse dendritic cell receptor DCIR binds to LRP1 N-glycans containing terminal galactoses, including the α-Gal antigen
B. B. A. Raymond, T. Sneperger, S. Rousset, N. Gilles, A. Bally, A. Stella, A. L. Hipgrave Ederveen, J. Marcoux, G. Trimaglio, M. Thepaut, F. Lagarrigue, O. Burlet-Schiltz, M. Wuhrer, F. Fieschi, P. Demange, , Y. Rombouts
This study identifies LRP1 N-glycans with terminal galactoses as ligands for DCIR, revealing its specificity in immune regulation and potential therapeutic applications.
bioRxiv · May 20, 2024 · PreprintImmunology